wife can't urinate, struggling to urinate, it is of concern to them as to why she can't urinate; body aches; pain in the arm; chills; Less than 6 months between primary series and booster; This spontaneous case was reported by a consumer and describes the occurrence of DYSURIA (wife can't urinate, struggling to urinate, it is of concern to them as to why she can't urinate), MYALGIA (body aches), VACCINATION SITE PAIN (pain in the arm), CHILLS (chills) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Less than 6 months between primary series and booster) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058F21A) for COVID-19 vaccination.     Previously administered products included for COVID-19 vaccination: JANSSEN COVID-19 VACCINE (Given in left non-dominant arm. Lot number is 180096.) on 21-Jun-2021. Past adverse reactions to the above products included No adverse event with JANSSEN COVID-19 VACCINE. Concomitant products included CANDESARTAN CILEXETIL (ATACAND) for an unknown indication.    On 19-Nov-2021 at 6:51 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Nov-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Less than 6 months between primary series and booster). On 20-Nov-2021 at 9:30 AM, the patient experienced DYSURIA (wife can't urinate, struggling to urinate, it is of concern to them as to why she can't urinate), MYALGIA (body aches), VACCINATION SITE PAIN (pain in the arm) and CHILLS (chills). On 19-Nov-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Less than 6 months between primary series and booster) had resolved. At the time of the report, DYSURIA (wife can't urinate, struggling to urinate, it is of concern to them as to why she can't urinate) and CHILLS (chills) had not resolved and MYALGIA (body aches) and VACCINATION SITE PAIN (pain in the arm) outcome was unknown.            Concomitant medications include Birth control and blood pressure medication. No treatment medication details was reported.  Company Comment: This is a Spontaneous case concerning a 37-year-old, female patient with medical history of birth control pills and blood pressure medication user,  who experienced the unexpected non serious event of Dysuria among other non serious events. The event occurred approximately 1 day after the booster dose of mRNA 1273 vaccine. This dose was given before the 6 months has passed since the first dose of COVID 19 vaccine Ad26.COV2-S, which is an Inappropriate schedule of vaccination.  The benefit-risk relationship of mRNA 1273 vaccine is not affected by this report.; Sender's Comments: This is a Spontaneous case concerning a 37-year-old, female patient with medical history of birth control pills and blood pressure medication user,  who experienced the unexpected non serious event of Dysuria among other non serious events. The event occurred approximately 1 day after the booster dose of mRNA 1273 vaccine. This dose was given before the 6 months has passed since the first dose of COVID 19 vaccine Ad26.COV2-S, which is an Inappropriate schedule of vaccination.  The benefit-risk relationship of mRNA 1273 vaccine is not affected by this report.